A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study With Vilazodone in Patients With Major Depressive Disorder
Phase of Trial: Phase IV
Latest Information Update: 13 Jul 2016
At a glance
- Drugs Vilazodone (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Sponsors Actavis; Forest Laboratories
- 17 May 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Oct 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Jan 2015 to 1 Feb 2015.
- 24 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.